Joseph Jordan Romano, D.O.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Doppler, Transcranial | 11 | 2012 | 292 | 0.900 |
Why?
|
| Intracranial Embolism | 8 | 2008 | 202 | 0.710 |
Why?
|
| Viral Nonstructural Proteins | 6 | 2015 | 241 | 0.520 |
Why?
|
| Macrocyclic Compounds | 6 | 2015 | 72 | 0.520 |
Why?
|
| Collateral Circulation | 2 | 2012 | 287 | 0.400 |
Why?
|
| Perceptual Disorders | 1 | 2012 | 196 | 0.370 |
Why?
|
| Cerebral Revascularization | 1 | 2012 | 238 | 0.350 |
Why?
|
| Hepacivirus | 6 | 2015 | 1379 | 0.350 |
Why?
|
| Visual Fields | 2 | 2012 | 1047 | 0.320 |
Why?
|
| Vasospasm, Intracranial | 2 | 2008 | 208 | 0.320 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2008 | 1018 | 0.310 |
Why?
|
| Hemianopsia | 1 | 2009 | 122 | 0.300 |
Why?
|
| Carotid Stenosis | 4 | 2012 | 854 | 0.300 |
Why?
|
| Stroke | 9 | 2012 | 9981 | 0.300 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 245 | 0.280 |
Why?
|
| Medical Audit | 1 | 2007 | 467 | 0.270 |
Why?
|
| Intracranial Aneurysm | 2 | 2008 | 1197 | 0.270 |
Why?
|
| Hemodynamics | 4 | 2012 | 4199 | 0.270 |
Why?
|
| Dyslipidemias | 2 | 2011 | 849 | 0.250 |
Why?
|
| Emergency Treatment | 1 | 2007 | 517 | 0.230 |
Why?
|
| Aneurysm, Ruptured | 1 | 2008 | 452 | 0.220 |
Why?
|
| Protease Inhibitors | 3 | 2012 | 791 | 0.220 |
Why?
|
| Migraine Disorders | 2 | 2012 | 1620 | 0.200 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 1261 | 0.190 |
Why?
|
| Embolism, Fat | 4 | 2007 | 47 | 0.180 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2019 | 33 | 0.180 |
Why?
|
| Benzothiazoles | 1 | 2019 | 248 | 0.160 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 2161 | 0.160 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2010 | 179 | 0.150 |
Why?
|
| Articulation Disorders | 1 | 1997 | 14 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2007 | 2158 | 0.150 |
Why?
|
| Basilar Artery | 3 | 2005 | 200 | 0.150 |
Why?
|
| Cerebral Arteries | 1 | 1999 | 494 | 0.150 |
Why?
|
| Brain Ischemia | 6 | 2008 | 3265 | 0.150 |
Why?
|
| Academic Medical Centers | 1 | 2007 | 2759 | 0.140 |
Why?
|
| Hypoglossal Nerve | 1 | 1997 | 95 | 0.140 |
Why?
|
| Vertebrobasilar Insufficiency | 2 | 2008 | 114 | 0.140 |
Why?
|
| Phosphates | 1 | 2019 | 786 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2008 | 8949 | 0.130 |
Why?
|
| Florida | 3 | 2011 | 435 | 0.130 |
Why?
|
| Carrier Proteins | 4 | 2012 | 5021 | 0.120 |
Why?
|
| Smoking | 1 | 2011 | 8987 | 0.120 |
Why?
|
| Dementia, Multi-Infarct | 2 | 2004 | 12 | 0.110 |
Why?
|
| Skull Base Neoplasms | 1 | 1997 | 284 | 0.110 |
Why?
|
| Quinazolinones | 1 | 2015 | 221 | 0.110 |
Why?
|
| Hypertension | 4 | 2011 | 8480 | 0.110 |
Why?
|
| Middle Cerebral Artery | 2 | 2012 | 264 | 0.110 |
Why?
|
| Quinazolines | 1 | 2019 | 1356 | 0.110 |
Why?
|
| Carotid Artery, Internal, Dissection | 2 | 2004 | 45 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 3 | 2012 | 2731 | 0.110 |
Why?
|
| Sulfones | 1 | 2015 | 437 | 0.110 |
Why?
|
| Hyperventilation | 1 | 2012 | 81 | 0.110 |
Why?
|
| Inhalation | 1 | 2012 | 143 | 0.100 |
Why?
|
| Visual Acuity | 2 | 2012 | 2530 | 0.100 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2009 | 895 | 0.100 |
Why?
|
| Caribbean Region | 1 | 2011 | 194 | 0.100 |
Why?
|
| Benzocycloheptenes | 1 | 2009 | 9 | 0.090 |
Why?
|
| Structure-Activity Relationship | 6 | 2012 | 3129 | 0.090 |
Why?
|
| Embolism | 2 | 2005 | 408 | 0.090 |
Why?
|
| Antiviral Agents | 2 | 2015 | 2987 | 0.090 |
Why?
|
| Heptanoic Acids | 1 | 2011 | 343 | 0.080 |
Why?
|
| Blood Flow Velocity | 4 | 2012 | 1423 | 0.080 |
Why?
|
| Labetalol | 1 | 2008 | 30 | 0.080 |
Why?
|
| Intracranial Hemorrhage, Hypertensive | 1 | 2008 | 20 | 0.080 |
Why?
|
| Vertebral Artery | 2 | 2008 | 192 | 0.080 |
Why?
|
| Glasgow Outcome Scale | 1 | 2008 | 109 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2007 | 7659 | 0.080 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2007 | 138 | 0.080 |
Why?
|
| Brain Infarction | 2 | 2011 | 299 | 0.080 |
Why?
|
| Time and Motion Studies | 1 | 2007 | 149 | 0.070 |
Why?
|
| Quinolines | 2 | 2012 | 732 | 0.070 |
Why?
|
| Microcirculation | 1 | 2011 | 1286 | 0.070 |
Why?
|
| Transportation of Patients | 1 | 2007 | 185 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2007 | 1462 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2007 | 1458 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2007 | 2737 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 647 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 2008 | 395 | 0.060 |
Why?
|
| Vertebral Artery Dissection | 1 | 2005 | 48 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 2012 | 1504 | 0.060 |
Why?
|
| Cerebral Infarction | 3 | 2005 | 1011 | 0.060 |
Why?
|
| Pyrroles | 1 | 2011 | 1146 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2010 | 1900 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2011 | 1151 | 0.060 |
Why?
|
| Dogs | 3 | 2019 | 3912 | 0.060 |
Why?
|
| Lateral Medullary Syndrome | 1 | 2002 | 9 | 0.060 |
Why?
|
| Humans | 35 | 2019 | 744343 | 0.060 |
Why?
|
| Image Enhancement | 2 | 2004 | 2921 | 0.060 |
Why?
|
| Cyclization | 2 | 2012 | 65 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 5535 | 0.050 |
Why?
|
| Drug Discovery | 3 | 2019 | 1058 | 0.050 |
Why?
|
| Middle Aged | 17 | 2012 | 213383 | 0.050 |
Why?
|
| Reflex, Abnormal | 1 | 2002 | 84 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 635 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2274 | 0.050 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2002 | 23 | 0.050 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 935 | 0.050 |
Why?
|
| Antihypertensive Agents | 2 | 2011 | 2046 | 0.050 |
Why?
|
| Cerebral Angiography | 5 | 2008 | 1285 | 0.050 |
Why?
|
| Acetazolamide | 1 | 2001 | 100 | 0.050 |
Why?
|
| Indoles | 1 | 2010 | 1839 | 0.050 |
Why?
|
| Half-Life | 2 | 2012 | 661 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2008 | 1530 | 0.050 |
Why?
|
| Carotid Artery, Internal | 2 | 2004 | 445 | 0.050 |
Why?
|
| Vertigo | 1 | 2002 | 202 | 0.050 |
Why?
|
| Male | 22 | 2019 | 350118 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2004 | 475 | 0.050 |
Why?
|
| Incidence | 3 | 2011 | 20947 | 0.050 |
Why?
|
| Serum Albumin | 1 | 2004 | 676 | 0.050 |
Why?
|
| Endocarditis | 1 | 2005 | 350 | 0.050 |
Why?
|
| Triage | 1 | 2007 | 976 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2012 | 2915 | 0.050 |
Why?
|
| Rats | 6 | 2015 | 24260 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 2418 | 0.040 |
Why?
|
| Corpus Callosum | 1 | 2004 | 737 | 0.040 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2007 | 944 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2004 | 850 | 0.040 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2002 | 478 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2009 | 2925 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2008 | 1392 | 0.040 |
Why?
|
| Female | 21 | 2012 | 380194 | 0.040 |
Why?
|
| Arm Injuries | 1 | 1999 | 160 | 0.040 |
Why?
|
| Leg Injuries | 1 | 1999 | 178 | 0.040 |
Why?
|
| Pyridines | 1 | 2009 | 2825 | 0.040 |
Why?
|
| Aged | 12 | 2011 | 163280 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2019 | 961 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 941 | 0.040 |
Why?
|
| Analgesics | 1 | 2004 | 1040 | 0.040 |
Why?
|
| Tongue Diseases | 1 | 1997 | 67 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 14722 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 3610 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3255 | 0.030 |
Why?
|
| Deglutition | 1 | 1997 | 197 | 0.030 |
Why?
|
| Area Under Curve | 2 | 2010 | 1654 | 0.030 |
Why?
|
| Reference Values | 1 | 2002 | 4982 | 0.030 |
Why?
|
| Kinetics | 2 | 2012 | 6473 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2012 | 35421 | 0.030 |
Why?
|
| Heparin | 1 | 2001 | 1637 | 0.030 |
Why?
|
| Animals | 8 | 2019 | 168757 | 0.030 |
Why?
|
| Retrospective Studies | 8 | 2012 | 77449 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 8301 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2007 | 4043 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2007 | 4371 | 0.030 |
Why?
|
| Liver | 3 | 2012 | 7474 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2015 | 5456 | 0.020 |
Why?
|
| Acute Disease | 3 | 2008 | 7149 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 9959 | 0.020 |
Why?
|
| Colitis | 1 | 2019 | 1170 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 7279 | 0.020 |
Why?
|
| Brain | 4 | 2012 | 26385 | 0.020 |
Why?
|
| Isoindoles | 1 | 2010 | 41 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 2011 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2012 | 698 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2011 | 63114 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2010 | 229 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2010 | 380 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 40075 | 0.020 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2009 | 70 | 0.020 |
Why?
|
| Echocardiography | 1 | 2002 | 5102 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 459 | 0.020 |
Why?
|
| Swine | 1 | 2019 | 5917 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2010 | 416 | 0.020 |
Why?
|
| Leucine | 1 | 2010 | 561 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2010 | 320 | 0.020 |
Why?
|
| Risk Factors | 3 | 2011 | 72290 | 0.020 |
Why?
|
| Proline | 1 | 2010 | 458 | 0.020 |
Why?
|
| Adolescent | 3 | 2012 | 85781 | 0.020 |
Why?
|
| Genotype | 2 | 2012 | 12951 | 0.020 |
Why?
|
| Hospitalization | 1 | 2007 | 10262 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2010 | 626 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 1150 | 0.020 |
Why?
|
| Protein S Deficiency | 1 | 2007 | 16 | 0.020 |
Why?
|
| Thioguanine | 1 | 2007 | 46 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 1999 | 1947 | 0.020 |
Why?
|
| Quality of Life | 1 | 2009 | 12804 | 0.020 |
Why?
|
| Cardiolipins | 1 | 2007 | 88 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2007 | 158 | 0.020 |
Why?
|
| Femoral Fractures | 2 | 2002 | 376 | 0.020 |
Why?
|
| Ischemic Preconditioning | 1 | 2007 | 92 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 39050 | 0.020 |
Why?
|
| Carbamates | 1 | 2008 | 196 | 0.020 |
Why?
|
| Snoring | 1 | 2007 | 191 | 0.020 |
Why?
|
| Asparaginase | 1 | 2007 | 236 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2010 | 1899 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2001 | 4599 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2007 | 57776 | 0.020 |
Why?
|
| Cytarabine | 1 | 2007 | 692 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 2 | 2007 | 2647 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2015 | 1591 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 1375 | 0.020 |
Why?
|
| Carrageenan | 1 | 2004 | 67 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3508 | 0.020 |
Why?
|
| Thrombophilia | 1 | 2007 | 305 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2011 | 8554 | 0.010 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2007 | 271 | 0.010 |
Why?
|
| Binding Sites | 1 | 2012 | 6114 | 0.010 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 460 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2010 | 2375 | 0.010 |
Why?
|
| Haiti | 1 | 2005 | 553 | 0.010 |
Why?
|
| Brain Edema | 1 | 2008 | 617 | 0.010 |
Why?
|
| Vasculitis | 1 | 2007 | 519 | 0.010 |
Why?
|
| Hematoma | 1 | 2008 | 758 | 0.010 |
Why?
|
| Adult | 8 | 2007 | 214055 | 0.010 |
Why?
|
| Cell Line | 2 | 2009 | 15997 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2886 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 964 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2011 | 2356 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2007 | 2559 | 0.010 |
Why?
|
| HIV Infections | 1 | 2007 | 16718 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2004 | 930 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 3527 | 0.010 |
Why?
|
| Thiazoles | 1 | 2008 | 1483 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2010 | 1938 | 0.010 |
Why?
|
| Brain Stem | 1 | 2005 | 846 | 0.010 |
Why?
|
| Hyperalgesia | 1 | 2004 | 502 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2007 | 1359 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 1198 | 0.010 |
Why?
|
| Migraine with Aura | 1 | 2001 | 203 | 0.010 |
Why?
|
| Thalamus | 1 | 2005 | 1023 | 0.010 |
Why?
|
| Mutation | 2 | 2015 | 29786 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1850 | 0.010 |
Why?
|
| Ulna Fractures | 1 | 1999 | 125 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2005 | 1133 | 0.010 |
Why?
|
| Cerebral Cortex | 2 | 2005 | 5708 | 0.010 |
Why?
|
| Posture | 1 | 2002 | 958 | 0.010 |
Why?
|
| Cerebellum | 1 | 2005 | 1488 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 5078 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2004 | 1406 | 0.010 |
Why?
|
| Fibula | 1 | 1999 | 269 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2004 | 1442 | 0.010 |
Why?
|
| Tibial Fractures | 1 | 1999 | 269 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4933 | 0.010 |
Why?
|
| Endarterectomy, Carotid | 1 | 2000 | 546 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2011 | 53288 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 9687 | 0.010 |
Why?
|
| Thoracic Surgery | 1 | 2000 | 719 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 1999 | 819 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1997 | 20129 | 0.010 |
Why?
|
| Radius Fractures | 1 | 1999 | 501 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2004 | 1886 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 10388 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 81183 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 10397 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10943 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 5756 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2004 | 2788 | 0.010 |
Why?
|
| Homeostasis | 1 | 2001 | 3340 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2007 | 12720 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15540 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2004 | 6150 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 18370 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 13284 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 12959 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11524 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2007 | 15295 | 0.000 |
Why?
|
| Obesity | 1 | 2007 | 12745 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2007 | 41006 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 15165 | 0.000 |
Why?
|
| Child | 1 | 2007 | 77709 | 0.000 |
Why?
|